Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01097902 · ClinicalTrials.gov registry record · Phase 1
Study of Experimental Models of Pain and Inflammation.
A Phase 1 study, sponsored by Martin Angst.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01097902: Completed Phase 1 study, sponsored by Martin Angst.
NCT01097902 is a Phase 1 study that has completed, run by Martin Angst. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01097902, a Phase 1 study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pain. We also hope to determine the measurable effects of a known non-steroidal anti-inflammatory drug (NSAID) on biomarkers of pain and inflammation.
Interventions
- DRUG Ibuprofen
- DRUG Placebo tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
What the finished NCT01097902 record still lists
NCT01097902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT01097902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01097902 about?
NCT01097902 is a clinical study titled "Study of Experimental Models of Pain and Inflammation.". The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pa...
What is the current status of trial NCT01097902?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01097902?
The interventions under investigation include: Ibuprofen (DRUG), Placebo tablet (DRUG).
Who is sponsoring clinical trial NCT01097902?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01097902's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia